Patients' perspectives regarding long-term warfarin therapy and the potential transition to new oral anticoagulant therapy.

PubWeight™: 0.80‹?›

🔗 View Article (PMC 4232500)

Published in Ther Adv Drug Saf on December 01, 2014

Authors

Elizabeth S Gebler-Hughes1, Linda Kemp1, Malcolm J Bond2

Author Affiliations

1: School of Medicine, Flinders University, Adelaide, SA, Australia.
2: School of Medicine, Health Sciences Building, Flinders University, GPO Box 2100, Adelaide, SA 5001, Australia.

Articles cited by this

Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med (2009) 39.97

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med (2011) 28.99

Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med (2011) 23.50

Constructions of masculinity and their influence on men's well-being: a theory of gender and health. Soc Sci Med (2000) 10.67

Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 4.82

The impact of long-term warfarin therapy on quality of life. Evidence from a randomized trial. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. Arch Intern Med (1991) 2.92

Attitudes of physicians regarding anticoagulation for atrial fibrillation: a systematic review. Age Ageing (2011) 1.94

Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale. Am Heart J (2010) 1.82

Warfarin knowledge in patients with atrial fibrillation: implications for safety, efficacy, and education strategies. Cardiology (2010) 1.53

The new oral anticoagulants. Blood (2009) 1.48

Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism. Patient Prefer Adherence (2010) 1.26

Warfarin--indications, risks and drug interactions. Aust Fam Physician (2010) 1.04

Old and new oral anticoagulants for venous thromboembolism and atrial fibrillation: a review of the literature. Thromb Res (2012) 0.99

Assessing the impact of dabigatran and warfarin on health-related quality of life: results from an RE-LY sub-study. Int J Cardiol (2013) 0.87

Health related quality of life of patients undergoing oral anticoagulation therapy. Rev Lat Am Enfermagem (2011) 0.85

New oral anticoagulants: which one should my patient use? Hematology Am Soc Hematol Educ Program (2012) 0.82

Quality of life of elderly people on warfarin for atrial fibrillation. Age Ageing (2009) 0.81

The RE-LY study: Randomized Evaluation of Long-term anticoagulant therapY: dabigatran vs. warfarin. Eur Heart J (2009) 0.81

Women and health care communication. Patient Educ Couns (1989) 0.80

Implications of new anticoagulants in primary practice. Int J Clin Pract (2013) 0.79

Transitions of care in patients receiving oral anticoagulants: general principles, procedures, and impact of new oral anticoagulants. J Cardiovasc Nurs (2012) 0.78